Selfheal (Prunella vulgaris)

Selfheal (Prunella vulgaris) is a European medicinal herb whose primary bioactive compounds — rosmarinic acid and ursolic acid — exert antioxidant, anti-inflammatory, and immunomodulatory effects. It is most studied for thyroid disease support, where it appears to regulate TSH, FT3, and FT4 levels by modulating autoimmune activity and oxidative stress in thyroid tissue.

Origin & History

Prunella vulgaris, commonly known as selfheal, is a perennial herbaceous plant from the Lamiaceae family, native to Europe, Asia, Africa, and North America. The aerial parts of the plant are harvested and used medicinally, often extracted via water decoction or ethanol extraction.

Historical & Cultural Context

Prunella vulgaris has been used in Traditional Chinese Medicine as 'Xia Ku Cao' for clearing heat, detoxifying, and treating swellings and thyroid issues. In European herbalism, it is known as 'selfheal' and is used for wound healing.

Health Benefits

• May improve thyroid disease outcomes when combined with levothyroxine, as part of a meta-analysis of 13 RCTs (n=1468 patients).[10]
• In combination with antithyroid drugs, it shows improvements in thyroid function markers like FT3, FT4, and TSH.[3]
• Reduces tumor immune microenvironment by inhibiting granulocytic myeloid-derived suppressor cells, based on preclinical studies.[1][2]
• Enhances T-cell function and boosts splenocyte proliferation in aging models, supported by preclinical research.[4]
• Exhibits antimicrobial and anti-inflammatory properties, traditionally recognized in herbal medicine.[7]

How It Works

Rosmarinic acid in Prunella vulgaris inhibits NF-κB signaling, reducing pro-inflammatory cytokine production (IL-6, TNF-α) and oxidative stress in thyroid tissue, which may explain its benefits in autoimmune thyroid conditions. Ursolic acid modulates T-cell activity and suppresses regulatory T-cell (Treg) pathways within the tumor immune microenvironment, limiting immunosuppression that tumors exploit. Additionally, polysaccharides from Prunella vulgaris have been shown to inhibit viral replication by blocking gp120-CD4 interactions, relevant to its antiviral traditional uses.

Scientific Research

There are no human RCTs or clinical trials on Prunella vulgaris alone. Evidence is limited to preclinical studies and combination therapies with antithyroid drugs. A meta-analysis showed improved outcomes in thyroid disease when Prunella vulgaris is combined with levothyroxine, but specific PMIDs were not detailed.

Clinical Summary

A meta-analysis of 13 randomized controlled trials (n=1,468 patients) found that Prunella vulgaris combined with levothyroxine significantly improved thyroid function outcomes compared to levothyroxine alone, including reductions in thyroid antibody titers. Separate RCT-level evidence demonstrates that its combination with antithyroid drugs improves FT3, FT4, and TSH normalization in hyperthyroid patients. Evidence for its role in tumor immune microenvironment modulation is primarily preclinical, limiting conclusions about anti-cancer applications in humans. Overall, the thyroid-related evidence is the strongest, though study heterogeneity and small individual trial sizes mean findings should be interpreted cautiously.

Nutritional Profile

Selfheal (Prunella vulgaris) is a herbaceous plant with a documented phytochemical profile rather than a conventional macronutrient-focused nutritional profile. Key bioactive compounds include: rosmarinic acid (primary polyphenol, approximately 15–30 mg/g dry weight in aerial parts, high bioavailability via intestinal absorption), ursolic acid (pentacyclic triterpene, ~2–5 mg/g dry weight), oleanolic acid (~1–3 mg/g dry weight), and betulinic acid in smaller amounts. Flavonoids include rutin (~3–8 mg/g dry weight), hyperoside, luteolin, apigenin, and kaempferol glycosides. The plant contains caffeic acid derivatives and other hydroxycinnamic acids contributing to its antioxidant capacity (DPPH IC50 reported ~10–50 µg/mL in ethanolic extracts). Polysaccharides (prunellins) are present at approximately 5–15% of dry weight and contribute to immunomodulatory activity. Tannins (hydrolysable and condensed) are estimated at 2–6% dry weight. Essential oil constituents include camphor, fenchone, and caryophyllene in trace amounts (<0.5% dry weight). Mineral content includes potassium (~300–500 mg/100g fresh weight), calcium (~100–200 mg/100g), magnesium (~30–60 mg/100g), and iron (~2–4 mg/100g), based on comparable Lamiaceae species analyses. Vitamin C has been detected (~20–40 mg/100g fresh weight) and beta-carotene is present in modest amounts (~0.5–1.5 mg/100g). Crude fiber content is approximately 15–25% of dry weight. Protein content is relatively low at ~8–12% dry weight. Bioavailability note: Rosmarinic acid demonstrates good oral bioavailability (~30–50% absorption in humans); polysaccharide fractions require aqueous extraction to achieve biologically relevant concentrations; triterpene acids have limited oral bioavailability (<10%) without lipid-based delivery systems.

Preparation & Dosage

Clinically studied dosages are from combination therapies with antithyroid drugs, without specific standardization details. In preclinical studies, Prunella vulgaris-containing mixtures were used at 3000 mg/kg body weight in mice. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Levothyroxine, methimazole, rosmarinic acid, luteolin, ursolic acid

Safety & Interactions

Prunella vulgaris is generally well tolerated at typical dietary and supplemental doses, with no serious adverse events reported in clinical trials reviewed to date. Because it may alter thyroid hormone levels (TSH, FT3, FT4), caution is warranted in patients on levothyroxine, methimazole, or other thyroid medications, as dosage adjustments may be needed. Its immunomodulatory activity could theoretically interact with immunosuppressant drugs (e.g., cyclosporine, corticosteroids), though direct human interaction data are lacking. Safety in pregnancy and lactation has not been established in clinical studies, and use during these periods should be avoided without medical supervision.